Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Jun 14, 2024
Episode
222
Soundcloud
Share
In episode two summarizing important lung cancer data presented at ASCO 2024, Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu cover the phase III CROWN trial, ROS1 NSCLC with a novel ROS1 TKI, taletrectinib, the MARIPOSA trial, the PALOMA-3 trial, the WU-KONG1 data, the BEAMION-Lung1 trial, and CheckMate 77T.
Guest
Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Delvys Rodriguez-Abreu
MD
Head of Medical Oncology
Hospital Universitario Insular de Gran Canaria
President of the Canarian Lung Cancer Foundation
Clarissa Mathias
MD, PhD
Medical Oncologist
NOB/Oncoclinicas Hospital Santa Izabel
ASCO International Quality Steering Group
President Brazilian Society of Clinical Oncology
